← Back to Clinical Trials
Recruiting NCT07572110

NCT07572110 Project Independence

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07572110
Status Recruiting
Phase
Sponsor University of Miami
Condition Accommodation
Study Type INTERVENTIONAL
Enrollment 70 participants
Start Date 2026-05-08
Primary Completion 2027-05

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Project Independence

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 70 participants in total. It began in 2026-05-08 with a primary completion date of 2027-05.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This project aims to develop and test the feasibility, acceptability, and preliminary impact of a brief, online single-session intervention (SSI) for caregivers of autistic youth ages 10 to 14. The SSI, called Project Independence, is designed to give caregivers practical tools to support greater independence in daily living routines. To test the SSI, participants will be randomly assigned to either complete Project Independence or watch a time-matched, series of educational video with unrelated content.

Eligibility Criteria

Inclusion Criteria: * Any adult (age 18+) who is a parent, family member, or legal caregiver and is one of the main adults responsible for the daily care of an autistic youth in the targeted age range for at least half of the time. * Those that currently reside in the United States * Those that have a mobile device (e.g., laptop, tablet, smartphone) or desktop computer and internet access sufficient for the delivery of the study assessments and online intervention * Those who may or may not report current clinically significant psychopathological symptoms (e.g., anxiety, depression, parental stress). Exclusion Criteria: * Adults unable to consent * Individuals who are not yet adults (i.e., infants, children, teenagers).

Contact & Investigator

Central Contact

Sandra L Cepeda, M.S.

✉ slc247@miami.edu

📞 305-284-2712

Principal Investigator

Jill Ehrenreich-May, Ph.D.

PRINCIPAL INVESTIGATOR

University of Miami

Frequently Asked Questions

Who can join the NCT07572110 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Accommodation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07572110 currently recruiting?

Yes, NCT07572110 is actively recruiting participants. Contact the research team at slc247@miami.edu for enrollment information.

Where is the NCT07572110 trial being conducted?

This trial is being conducted at Coral Gables, United States.

Who is sponsoring the NCT07572110 clinical trial?

NCT07572110 is sponsored by University of Miami. The principal investigator is Jill Ehrenreich-May, Ph.D. at University of Miami. The trial plans to enroll 70 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology